Research & Development Manager, Bio-Rad Laboratories
BIOGRAPHY
FEB 28, 2023 8:00 AM PST
Role of serology for congenital infections and vaccine-preventable diseases in the prenatal setting
Speakers
-
Alan Wu, PhD. D.A.B.C.C.
Professor, Lab Medicine, University of California, San Francisco. Co-core Lab Director, Zuckerberg San Francisco General HospitalBIOGRAPHY
Event Date & Time
Date: February 28, 2023
Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET)
Abstract
Prenatal infections can increase the risk of serious health complications including miscarriage, organ damage, birth defect, or even death. Prevention of prenatal infection begins with taking precautions to avoid maternal infections.
Serology testing is a valuable tool in preventing prenatal infections by identifying maternal immune status. Testing for immune status prior to pregnancy allows clinicians to determine if vaccinations are needed for measles, mumps, and varicella. For infections without vaccines, serology testing is valuable for several purposes. For one, seronegative results suggest behavior modifications to minimize the risk of infection. Additionally, serology results can be used as part of a diagnostic workup for pregnant women suspected of infection.
This webinar will provide an understanding of prenatal infections and will discuss the role of serology testing in preventing congenital infections.
Learning Objectives
- Summarize key congenital infections.
- Discuss the value of prenatal serology testing for TORCH , measles, and VZV.
- Identify clinical laboratory challenges with using serological testing to determine prenatal infections.
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...